The ovaries sit at the centre of fertility, hormones and whole-body vitality. When ovarian function declines, skin quality, mood, bone health and cardiovascular resilience all suffer. Stem cell ovarian rejuvenation focuses on repairing ovarian tissue and supporting hormone recovery at the source.
The ovaries are the primary source of estrogen and progesterone. Once function starts to decline, the impact reaches far beyond fertility, affecting skin quality, bone density, cardiovascular health, mood and sleep.
Premature ovarian insufficiency (POI) refers to ovarian decline before age 40 and affects roughly 1–3% of women. Broader ovarian aging often begins quietly around age 35. Traditional hormone replacement can temporarily supplement hormones, while stem cell therapy aims to repair ovarian tissue itself and support endogenous hormone production.
Our partner institutions work with one of Japan's largest stem cell culture research centres, with core expertise linked to the University of Tokyo. Proprietary rejuvenation, granule-culture and double-wash processes help keep every infusion at peak viability.
If you have one or more of the following, seek professional evaluation early
Irregular cycles, very light flow or periods stopping earlier than expected
Low AMH results suggesting diminished ovarian reserve
Difficulty conceiving naturally or repeated IVF setbacks linked to ovarian function
Hot flashes, night sweats, mood swings or sleep disruption before age 40
Ovarian damage and hormone disruption after chemotherapy or other cancer treatment
Persistent fatigue and reduced concentration associated with hormone imbalance
Falling estrogen levels accelerating bone loss and osteoporosis risk
Dryness, reduced elasticity and dull skin linked to estrogen decline
Core scientific leadership traces back to the University of Tokyo and focuses on women's reproductive endocrinology, with more than a decade of experience in ovarian repair.
Patented granule-culture methods and intensive low-passage handling help each batch pass strict quality checks before infusion.
A proprietary double-wash process removes residual medium before infusion, improving in-body survival and targeted ovarian migration.
Collection, culture and infusion all happen inside the same certified institution, avoiding frozen transport and minimizing activity loss.
Each session delivers 250–300 million high-activity cells, roughly 3–5 times common international dosing, to improve the chance of meaningful ovarian repair.
Partner institutions hold the required MHLW treatment plan numbers and PMDA-linked compliance approvals, providing a strong legal and safety foundation in Japan.
Within 3–6 months of treatment, clients report these significant changes
Hormone secretion becomes more stable, cycles often normalize and menstrual symptoms may ease.
AMH may improve, FSH may move closer to range and ovarian reserve indicators can show recovery.
Estrogen and progesterone balance may improve, easing hot flashes, night sweats and mood fluctuation.
Healthier estrogen support can improve skin elasticity, dryness and overall radiance.
Better hormone balance often supports sleep quality, energy recovery and less day-to-day fatigue.
Some patients with ovarian insufficiency recover natural ovulation, opening new fertility possibilities after specialist review.
Understanding this cutting-edge women's health therapy